Clearline Capital’s Flexion Therapeutics, Inc. FLXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-1,910,153
| Closed | -$11.7M | – | 201 |
|
|
2021
Q3 | $11.7M | Sell |
1,910,153
-213,546
| -10% | -$1.3M | 1.1% | 25 |
|
|
2021
Q2 | $17.5M | Buy |
2,123,699
+720,322
| +51% | +$5.93M | 2.6% | 9 |
|
|
2021
Q1 | $12.6M | Buy |
+1,403,377
| New | +$12.6M | 1.63% | 13 |
|
|
2020
Q4 | – | Sell |
-399,159
| Closed | -$4.16M | – | 109 |
|
|
2020
Q3 | $4.16M | Sell |
399,159
-126,574
| -24% | -$1.32M | 1.09% | 32 |
|
|
2020
Q2 | $6.91M | Buy |
+525,733
| New | +$6.91M | 2.25% | 18 |
|
|
2019
Q4 | – | Sell |
-797,987
| Closed | -$10.9M | – | 74 |
|
|
2019
Q3 | $10.9M | Sell |
797,987
-112,555
| -12% | -$1.54M | 4.98% | 3 |
|
|
2019
Q2 | $11.2M | Buy |
910,542
+353,832
| +64% | +$4.35M | 5.47% | 2 |
|
|
2019
Q1 | $6.95M | Buy |
556,710
+422,316
| +314% | +$5.27M | 3.63% | 9 |
|
|
2018
Q4 | $1.52M | Sell |
134,394
-256,682
| -66% | -$2.9M | 1.04% | 32 |
|
|
2018
Q3 | $7.32M | Buy |
391,076
+181,736
| +87% | +$3.4M | 4.33% | 6 |
|
|
2018
Q2 | $5.41M | Buy |
+209,340
| New | +$5.41M | 3.52% | 8 |
|